Valerie Ray
Directeur des opérations chez PhotonPharma, Inc.
Profil
Valerie Ray is currently the Vice President-Internal Operations at PhotonPharma, Inc. Prior to this, she worked as the Executive Director-Manufacturing at LightDeck Diagnostics, Inc. and as the Vice President-Operations at Encision, Inc. from 2014 to 2017.
She also worked as a Program Manager at Baxter Corporation Englewood and as a Product Manager at Terumo BCT, Inc. Dr. Ray holds a graduate degree from the University of Colorado Boulder, an MBA from Daniels College of Business, and an undergraduate degree from the University of Colorado Denver.
Postes actifs de Valerie Ray
| Sociétés | Poste | Début |
|---|---|---|
PhotonPharma, Inc.
 PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is developing the Innocell therapeutic cancer vaccine, which is a personalized therapy using autologous tumor tissue. The company is based in Fort Collins, CO at the Research Innovation Center of Colorado State University. The technology is based on a photochemical inactivation platform that uses riboflavin (vitamin B2) and UV light to render tumor cells incapable of replication while still allowing them to metabolize, express proteins, present antigens, and stimulate immune recognition and response mechanisms. In combination with selected adjuvants, Innocell has shown the ability to prevent metastatic tumor formation, reduce tumor growth, and stimulate cellular immune response pathways in preclinical animal models. The company was founded in 2018 by Raymond Goodrich, and Alan S. Rudolph has been the CEO since 2018. | Directeur des opérations | - |
Anciens postes connus de Valerie Ray
| Sociétés | Poste | Fin |
|---|---|---|
| ENCISION INC. | Directeur des opérations | 15/03/2017 |
Terumo BCT, Inc.
 Terumo BCT, Inc. Medical DistributorsDistribution Services Terumo BCT, Inc. develops and provides blood component and cellular technologies with the combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company offers products in the areas of apheresis collections, therapeutic apheresis, cell therapy systems, and whole blood processing and pathogen reduction technologies. Its products include information systems, data collection systems, apheresis systems, pathogen reduction technology systems, whole blood processing systems, orbisac systems, cell expansion systems, IIB sterile tubing welders, blood bags, and blood bag systems. The company was founded by Robert Collins and Randall Bellows in 1964 and is headquartered in Lakewood, CO. | Corporate Officer/Principal | - |
LightDeck Diagnostics, Inc.
 LightDeck Diagnostics, Inc. BiotechnologyHealth Technology Lightdeck Diagnostics engages in the development of clinical diagnostics and sample testing products. It offers the LightDeck platform, which consists of portable fluorescence analyzer and disposable, multiplex test cartridges. Its products are used in the medical, veterinary, environmental, food, agricultural, and military market segments. The company was founded by Christopher J. Myatt, Michael J. Lockhead, and Sarah C. Hatcher in 2009 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - |
Baxter Corporation Englewood
 Baxter Corporation Englewood Electronic Equipment/InstrumentsElectronic Technology Baxter Corporation Englewood engages in the provision of medical device solutions. The company was founded by Ronald Baxa and Brian E. Baldwin in 1975 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Formation de Valerie Ray
| University of Colorado Denver | Undergraduate Degree |
| University of Colorado Boulder | Graduate Degree |
| Daniels College of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENCISION INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Baxter Corporation Englewood
Baxter Corporation Englewood Electronic Equipment/InstrumentsElectronic Technology Baxter Corporation Englewood engages in the provision of medical device solutions. The company was founded by Ronald Baxa and Brian E. Baldwin in 1975 and is headquartered in Deerfield, IL. | Electronic Technology |
LightDeck Diagnostics, Inc.
LightDeck Diagnostics, Inc. BiotechnologyHealth Technology Lightdeck Diagnostics engages in the development of clinical diagnostics and sample testing products. It offers the LightDeck platform, which consists of portable fluorescence analyzer and disposable, multiplex test cartridges. Its products are used in the medical, veterinary, environmental, food, agricultural, and military market segments. The company was founded by Christopher J. Myatt, Michael J. Lockhead, and Sarah C. Hatcher in 2009 and is headquartered in Boulder, CO. | Health Technology |
Terumo BCT, Inc.
Terumo BCT, Inc. Medical DistributorsDistribution Services Terumo BCT, Inc. develops and provides blood component and cellular technologies with the combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company offers products in the areas of apheresis collections, therapeutic apheresis, cell therapy systems, and whole blood processing and pathogen reduction technologies. Its products include information systems, data collection systems, apheresis systems, pathogen reduction technology systems, whole blood processing systems, orbisac systems, cell expansion systems, IIB sterile tubing welders, blood bags, and blood bag systems. The company was founded by Robert Collins and Randall Bellows in 1964 and is headquartered in Lakewood, CO. | Distribution Services |
PhotonPharma, Inc.
PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is developing the Innocell therapeutic cancer vaccine, which is a personalized therapy using autologous tumor tissue. The company is based in Fort Collins, CO at the Research Innovation Center of Colorado State University. The technology is based on a photochemical inactivation platform that uses riboflavin (vitamin B2) and UV light to render tumor cells incapable of replication while still allowing them to metabolize, express proteins, present antigens, and stimulate immune recognition and response mechanisms. In combination with selected adjuvants, Innocell has shown the ability to prevent metastatic tumor formation, reduce tumor growth, and stimulate cellular immune response pathways in preclinical animal models. The company was founded in 2018 by Raymond Goodrich, and Alan S. Rudolph has been the CEO since 2018. | Health Technology |
